| AgACC | Ag000340 |
| Date | 11-02-2007 |
| Last updated | 14-12-2016 |
| Antigen Name | BCR |
| Common Name | Breakpoint cluster region |
| Full Name | Breakpoint cluster region protein |
| Synonym | Renal carcinoma antigen NY-REN-26; breakpoint cluster region; ALL; BCR1; CML; D22S11; D22S662; EC 2.7.11.1; FLJ16453; PHL
another display format
- Renal carcinoma antigen NY-REN-26
- breakpoint cluster region
- ALL
- BCR1
- CML
- D22S11
- D22S662
- EC 2.7.11.1
- FLJ16453
- PHL
|
| UniProt ID | P11274
|
| NCBI Gene ID | 613 |
| GeneCard ID | GC22P023179 |
| Comment | This is a splice isoform. |
| Annotation | This is a full length sequence. |
| Isoforms | Ag000339
Alignment of all Isoforms |
| Mutation entries | Ag003859, Ag003860, Ag003861, Ag003862, Ag003863, Ag003864, Ag003865, Ag003866, Ag003867, Ag003868, Ag003869, Ag003870, Ag003871, Ag003872, Ag003873, Ag003874
View mutation map |
| RNA/protein expression profile | RNA and protein Expression profile |
| T cell epitope | Epitope sequence | Position | HLA allele | Reference |
| FMVELVEGA | 714-722 | A2 |
9295046 |
| KLSEQESLL | 817-825 | A2 |
9295046 |
| MLTNSCVKL | 881-889 | A2 |
9295046 |
| HLA ligand | Ligand Sequence | Position | HLA allele | Reference |
| FLLDHLKRV | 1137-1145 | A*0201 |
9389712 |
| Predicted HLA binders | |
| Antigen sequence | MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERCKASIRRLEQEVNQERFRMIYLQTLLAKEKKSY
DRQRWGFRRAAQAPDGASEPRASASRPQPAPADGADPPPAEEPEARPDGEGSPGKARPGTARRPGAAASG
ERDDRGPPASVAALRSNFERIRKGHGQPGADAEKPFYVNVEFHHERGLVKVNDKEVSDRISSLGSQAMQM
ERKKSQHGAGSSVGDASRPPYRGRSSESSCGVDGDYEDAELNPRFLKDNLIDANGGSRPPWPPLEYQPYQ
SIYVGGMMEGEGKGPLLRSQSTSEQEKRLTWPRRSYSPRSFEDCGGGYTPDCSSNENLTSSEEDFSSGQS
SRVSPSPTTYRMFRDKSRSPSQNSQQSFDSSSPPTPQCHKRHRHCPVVVSEATIVGVRKTGQIWPNDGEG
AFHGDADGSFGTPPGYGCAADRAEEQRRHQDGLPYIDDSPSSSPHLSSKGRGSRDALVSGALESTKASEL
DLEKGLEMRKWVLSGILASEETYLSHLEALLLPMKPLKAAATTSQPVLTSQQIETIFFKVPELYEIHKEF
YDGLFPRVQQWSHQQRVGDLFQKLASQLGVYRAFVDNYGVAMEMAEKCCQANAQFAEISENLRARSNKDA
KDPTTKNSLETLLYKPVDRVTRSTLVLHDLLKHTPASHPDHPLLQDALRISQNFLSSINEEITPRRQSMT
VKKGEHRQLLKDSFMVELVEGARKLRHVFLFTDLLLCTKLKKQSGGKTQQYDCKWYIPLTDLSFQMVDEL
EAVPNIPLVPDEELDALKIKISQIKNDIQREKRANKGSKATERLKKKLSEQESLLLLMSPSMAFRVHSRN
GKSYTFLISSDYERAEWRENIREQQKKCFRSFSLTSVELQMLTNSCVKLQTVHSIPLTINKEDDESPGLY
GFLNVIVHSATGFKQSSNLYCTLEVDSFGYFVNKAKTRVYRDTAEPNWNELDPQALQDRDWQRTVIAMNG
IEVKLSVKFNSREFSLKRMPSRKQTGVFGVKIAVVTKRERSKVPYIVRQCVEEIERRGMEEVGIYRVSGV
ATDIQALKAAFDVNNKDVSVMMSEMDVNAIAGTLKLYFRELPEPLFTDEFYPNFAEGIALSDPVAKESCM
LNLLLSLPEANLLTFLFLLDHLKRVAEKEAVNKMSLHNLATVFGPTLLRPSEKESKLPANPSQPITMTDS
WSLEVMSQVQVLLYFLQLEAIPAPDSKRQSILFSTEV |